XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 10,085 $ 11,224 $ 27,285 $ 30,049
General and administrative 3,831 2,863 11,823 9,232
Total operating expenses 13,916 14,087 39,108 39,281
Loss from operations (13,916) (14,087) (39,108) (39,281)
Other income (expense):        
Interest income, net 2,101 826 4,633 2,759
Other expense, net (2) (11) (16) (17)
Interest expense 0 (1) 0 (3)
Total other income, net 2,099 814 4,617 2,739
Loss before income taxes (11,817) (13,273) (34,491) (36,542)
Income tax benefit 15 31 48 46
Net loss $ (11,802) $ (13,242) $ (34,443) $ (36,496)
Basic net loss per common share outstanding $ (0.08) $ (0.13) $ (0.26) $ (0.36)
Diluted net loss per common share outstanding $ (0.08) $ (0.13) $ (0.26) $ (0.36)
Weighted average common shares used in net loss per share attributable to common stockholders, basic 145,104,986 101,282,228 131,122,754 100,616,111
Weighted average common shares used in net loss per share attributable to common stockholders, diluted 145,104,986 101,282,228 131,122,754 100,616,111
Net loss $ (11,802) $ (13,242) $ (34,443) $ (36,496)
Other comprehensive income (loss):        
Net unrealized gains (losses) on available-for-sale marketable securities 6 223 (31) 168
Comprehensive loss $ (11,796) $ (13,019) $ (34,474) $ (36,328)